Steris has a total of 3838 patents globally, out of which 2346 have been granted. Of these 3838 patents, more than 57% patents are active. United States of America is where Steris has filed the maximum number of patents, followed by Europe and Australia. Parallelly, USA seems to be the main focused R&D center and also is the origin country of Steris.
Steris was founded in 1985 by Raymond Kralovic. Steris provides medical products and services. The Company offers a wide range of infection prevention and procedural surgical products. STERIS serves healthcare, pharmaceutical, and medical device customers worldwide. As of May 2022, Steris has a market cap of $22.53 Billion.
Read about some of the most popular patents of Steris which have been covered by us in this article and also you can find Steris patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Steris patent portfolio.
How many patents does the Founder and CEO of Steris have?
The Founder Rudolf Raymond Kralovic has 0 patents and the CEO Dan Carestio have 0 patents.
How many patents does Steris have?
Steris has a total of 3838 patents globally. These patents belong to 884 unique patent families. Out of 3838 patents, 2220 patents are active.
How Many Patents did Steris File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Steris Applications Filed | Steris Patents Granted |
| 2011 | 120 | 94 |
| 2012 | 101 | 120 |
| 2013 | 211 | 100 |
| 2014 | 235 | 113 |
| 2015 | 167 | 109 |
| 2016 | 122 | 139 |
| 2017 | 130 | 160 |
| 2018 | 207 | 142 |
| 2019 | 125 | 147 |
| 2020 | 103 | 134 |
| 2021 | 64 | 154 |
| 2022 | 6 | 49 |
How many Steris patents are Alive/Dead?
Worldwide Patents
How Many Patents did Steris File in Different Countries?
Countries in which Steris Filed Patents
| Country | Patents |
| United States Of America | 726 |
| Europe | 437 |
| Australia | 296 |
| Canada | 282 |
| Germany | 269 |
| Japan | 241 |
| Spain | 210 |
| Mexico | 150 |
| India | 147 |
| China | 115 |
| United Kingdom | 92 |
| Austria | 88 |
| Taiwan | 72 |
| Korea (South) | 64 |
| Brazil | 61 |
| Hong Kong (S.A.R.) | 51 |
| France | 27 |
| Malaysia | 23 |
| Denmark | 16 |
| New Zealand | 8 |
| Poland | 7 |
| Portugal | 6 |
| Argentina | 5 |
| Norway | 5 |
| Israel | 5 |
| South Africa | 4 |
| Russia | 4 |
| Slovenia | 3 |
| Czech Republic | 3 |
| Singapore | 3 |
| Colombia | 3 |
| Georgia | 2 |
| Indonesia | 2 |
| Croatia | 2 |
| Slovakia | 2 |
| Viet Nam | 2 |
| Ecuador | 2 |
| Hungary | 2 |
| Philippines | 2 |
| Yugoslavia/Serbia and Montenegro | 2 |
| Costa Rica | 2 |
| Morocco | 2 |
| Ukraine | 1 |
| Saudi Arabia | 1 |
| Estonia | 1 |
Where are Research Centers of Steris Patents Located?
10 Best Steris Patents
US6591239B1 is the most popular patent in the Steris portfolio. It has received 2016 citations so far from companies like Virtual Incision Corporation, Smith & Nephew, Inc and Voicebox Technologies Corporation.
Below is the list of 10 most cited patents of Steris:
| Publication Number | Citation Count |
| US6591239B1 | 216 |
| US6633328B1 | 164 |
| US7089612B2 | 157 |
| US6383505B1 | 117 |
| US6463123B1 | 116 |
| US6378149B1 | 112 |
| US6598275B1 | 109 |
| US6387238B1 | 108 |
| US20070270752A1 | 107 |
| US20080306759A1 | 105 |
Which Companies are using Steris Patents to Advance their Research?
If patents or patents from a particular technology area of a company receive a lot of citations, it implies that the technology is being followed and incrementally innovated by the citing companies. It also indicates that citing companies are working on similar and closely related technologies.
The top citing companies in the Steris patent portfolio are United States Endoscopy Group Inc, 3M Innovative Properties Company and Olympus Corporation.
List of the top forward citing Companies –
| Company | Number of Patents |
| United States Endoscopy Group Inc | 14 |
| 3M Innovative Properties Company | 13 |
| Olympus Corporation | 11 |
| Covidien | 10 |
| Boston Scientific Scimed Inc | 8 |
| Bank Of America | 7 |
| Krones | 7 |
| Stryker Corporation | 5 |
| Ecolab Usa Inc | 5 |
| Endochoice Inc | 5 |
Count of 102 and 103 Type Rejections based on Steris Patents
Top Steris Patents used in Rejecting Most Patent Applications
| Patent Number | Count of Rejected Applications |
| US6967315B2 | 18 |
| US7186374B2 | 14 |
| US20080306759A1 | 12 |
| US6964788B2 | 12 |
| US6734405B2 | 12 |
| US6387238B1 | 12 |
| US6906296B2 | 12 |
| US7354551B2 | 11 |
| US20050129571A1 | 11 |
| US7803315B2 | 10 |
| US7946288B2 | 9 |
| US6919057B2 | 9 |
| US6463123B1 | 8 |
| US7700056B2 | 8 |
| US6746613B2 | 8 |
What Percentage of Steris US Patent Applications were Granted?
Steris (Excluding its subsidiaries) has filed 328 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 282 have been granted leading to a grant rate of 87.7%.
Below are the key stats of Steris patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Steris?
| Law Firm | Total Applications | Success Rate |
| Fay Sharpe Llp | 139 | 97.12% |
| Kusner & Jaffe | 113 | 79.28% |
| Hudak Shunk & Farine Co Lpa | 17 | 87.50% |
| Renner Otto Boisselle & Sklar Llp | 12 | 91.67% |
| S C Johnson & Son Inc | 11 | 90.91% |
| Thomas E Kocovsky Jr | 10 | 60.00% |
| Mark Kusner | 6 | 75.00% |
| Fay Sharpe Beall Fagan | 4 | 75.00% |
| Westman Champlin & Koehler Pa | 3 | 100.00% |
| Thomas E Kocovsky | 2 | 100.00% |
EXCLUSIVE INSIGHTS COMING SOON!
What are Steris key innovation segments?